Previous 10 | Next 10 |
The following slide deck was published by Phibro Animal Health Corporation in conjunction with their 2022 Q2 earnings call. For further details see: Phibro Animal Health Corporation 2022 Q2 - Results - Earnings Call Presentation
Phibro Animal Health Corporation (PAHC) Q2 2022 Earnings Conference Call February 10, 2022 09:00 ET Company Participants Damian Finio - Chief Financial Officer Jack Bendheim - Chairman, President & Chief Executive Officer Daniel Bendheim - Director & Executive Vice President of Corpor...
JUPITER, Fla., Feb. 10, 2022 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI), a global biotechnology company focused on further improving, applying, and deploy...
Phibro Animal press release (NASDAQ:PAHC): Q2 Non-GAAP EPS of $0.37 beats by $0.04. Revenue of $233M (+5.6% Y/Y) beats by $17.72M. For further details see: Phibro Animal Non-GAAP EPS of $0.37 beats by $0.04, revenue of $233M beats by $17.72M
Phibro Animal Health Corporation (Nasdaq:PAHC) today announced financial results for its second quarter ended December 31, 2021. Highlights for the three months ended December 31, 2021 (compared to the three months ended December 31, 2020) Net sales of $233 million, an increas...
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the BofA Securities 2022 Virtual Animal Health Summit. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and...
Biotech stocks have been hammered back to back for two years in a row now. The last time the SPDR ETF suffered a drop of 15% or more was in 2018, and the fund followed it up with a 33% increase in 2019. It dropped more than 15% in 2016 and followed that up with […] For further detail...
Phibro Animal Health Corporation (NASDAQ:PAHC): Today, the Food and Drug Administration (FDA) provided notice in the Federal Register of its intention to hold a public hearing regarding Mecadox ® (carbadox). Mecadox has been approved and sold in the United States for 50 years a...
Phibro Animal Health Corporation (Nasdaq:PAHC) expects to announce its second quarter financial results on Wednesday, February 9, 2022, after the market closes. Phibro management will host a conference call and webcast on Thursday, February 10, 2022, at 9:00 AM Eastern Time. Interes...
Phibro Animal Health Corporation (NASDAQ:PAHC) announced today that it will participate in the 4 th Annual Evercore ISI Virtual Conference. Chief Financial Officer Damian Finio and Executive Vice President, Corporate Strategy Daniel Bendheim will address financial analysts and i...
News, Short Squeeze, Breakout and More Instantly...
Phibro Animal Health Corporation Company Name:
PAHC Stock Symbol:
NASDAQ Market:
Phibro Animal Health Corporation Website:
Phibro Animal Health Corporation (Nasdaq: PAHC) proudly announces its third annual Environmental, Social and Governance (ESG) Report, highlighting 2023 achievements. At Phibro, the connections between people, animals and the planet drive us to optimize animal health and nutrition for better lives...
2024-06-04 09:00:27 ET Phibro Animal Health Corp. (PAHC) declaring a stock dividend of $0.12 per share on Ex-Date : June 05, 2024. Shareholders on record as of June 05, 2024 are eligible for the dividend. The payment date is scheduled for June 26, 2024, and the declaration was offic...
2024-05-23 05:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...